+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

From
From
From
From
From
From
From
From
From
From
Canada Insulin Delivery Market Outlook to 2033 - Product Thumbnail Image

Canada Insulin Delivery Market Outlook to 2033

  • Report
  • December 2024
  • 34 Pages
  • Canada
From
Australia Insulin Delivery Market Outlook to 2033 - Product Thumbnail Image

Australia Insulin Delivery Market Outlook to 2033

  • Report
  • December 2024
  • 31 Pages
  • Australia
From
India Insulin Delivery Market Outlook to 2033 - Product Thumbnail Image

India Insulin Delivery Market Outlook to 2033

  • Report
  • December 2024
  • 30 Pages
  • India
From
Germany Insulin Delivery Market Outlook to 2033 - Product Thumbnail Image

Germany Insulin Delivery Market Outlook to 2033

  • Report
  • December 2024
  • 31 Pages
  • Germany
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more